Taxol®, which is also known as paclitaxel, is a chemotherapeutic agent widely used to treat
different cancers. Since the discovery of its antitumoral activity, Taxol® has been used to …

Persistent cancer cells are the discrete and usually undetected cells that survive cancer drug
treatment and constitute a major cause of treatment failure. These cells are characterized by …

Since 1984, when paclitaxel was approved by the FDA for the treatment of advanced
ovarian carcinoma, taxanes have been widely used as microtubule-targeting antitumor …

Sonodynamic therapy (SDT) has gained significant attention in the treatment of deep tumors
and multidrug-resistant (MDR) bacterial infections due to its high tissue penetration depth …

A minor population of cancer cells may evade cell death from chemotherapy and targeted
therapy by entering a reversible slow proliferation state known as the drug tolerant persister …

Therapy resistance has long been considered to occur through the selection of pre-existing
clones equipped to survive and quickly regrow, or through the acquisition of mutations …

Drug-tolerant persister (DTP) cells have attracted significant interest, given their
predominant role in treatment failure. In this respect, DTP cells reportedly survive after …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal diseases, characterized
by a treatment-resistant and invasive nature. In line with these inherent aggressive …

An important stage in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) life
cycle is the binding of the spike (S) protein to the angiotensin converting enzyme-2 (ACE2) …

Low-intensity ultrasound-triggered sonodynamic therapy (SDT) is a promising noninvasive
therapeutic modality due to its strong tissue penetration ability. In recent years, with the …